Aslan Fred

Insider profile

Performance

Overall performance
2.3

Performance over holding periods
2.3
30 days 90 days 120 days
Average return 29% 8.2% 15.1%
Success rate 82% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Aslan Fred's trades of Artiva Biotherapeutics Inc's stock


Loading...
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
3.25
Quantity 6,375
Value US$20,719
Transaction date
Proposed sale
Price
2.77
Quantity 25,500
Value US$70,635
Transaction date
Proposed sale
Price
2.70
Quantity 25,500
Value US$68,850
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-11-18 2026-11-17 S Sale
34,263 -2.2%
359.01
US$1,402,248
34,263 -2.2% 359.01 US$1,402,248
2026-11-03 2026-11-02 S Sale
59,953 +35.0%
29.53
US$4,934,783
59,953 +35.0% 29.53 US$4,934,783
2026-10-07 2026-10-06 PlS Planned sale
79,053 +2.6%
346.72
US$2,738,813
79,053 +2.6% 346.72 US$2,738,813
2026-10-06 2026-10-06 PrS Proposed sale
34,465
7.13
US$245,735
34,465 7.13 US$245,735
2026-10-06 2026-10-05 S Sale
61,696 -3.8%
6.84
US$421,828
61,696 -3.8% 6.84 US$421,828
2026-09-09 2026-09-08 PlS Planned sale
23,429 -1.6%
10.92
US$255,746
23,429 -1.6% 10.92 US$255,746
2026-09-08 2026-09-08 PrS Proposed sale
23,429
11.19
US$262,171
23,429 11.19 US$262,171
2026-09-04 2026-09-03 S Sale
61,888 -4.0%
11.16
US$690,392
61,888 -4.0% 11.16 US$690,392
2026-05-19 2026-05-19 S Sale
27,116 -1.7%
9.01
US$244,253
27,116 -1.7% 9.01 US$244,253
2026-05-18 2026-05-18 PrS Proposed sale
28,000
9.22
US$258,160
28,000 9.22 US$258,160
2025-12-15 2025-12-15 PrS Proposed sale
12,749
3.30
US$42,072
12,749 3.30 US$42,072
2025-12-15 2025-12-15 PlS Planned sale
3,187 -0.3%
6.00
US$19,122
3,187 -0.3% 6.00 US$19,122
2025-11-17 2025-11-17 PrS Proposed sale
6,375
3.25
US$20,719
6,375 3.25 US$20,719
2025-11-17 2025-11-17 PlS Planned sale
6,375 -1.8%
3.38
US$21,522
6,375 -1.8% 3.38 US$21,522
2025-10-17 2025-10-17 PrS Proposed sale
25,500
2.77
US$70,635
25,500 2.77 US$70,635
2025-10-17 2025-10-17 PlS Planned sale
25,500 -6.7%
6.00
US$153,000
25,500 -6.7% 6.00 US$153,000
2025-08-18 2025-08-15 PlS Planned sale
25,500 -6.2%
2.73
US$69,579
25,500 -6.2% 2.73 US$69,579
2025-08-15 2025-08-15 PrS Proposed sale
25,500
2.70
US$68,850
25,500 2.70 US$68,850